Saluda Medical (ASX:SLD) appointed Chief Commercial Officer Mike Mathias as its new CEO to succeed Barry Regan, according to a Monday filing with the Australian bourse.
Mathias, who joined Saluda as chief commercial officer in November 2024, will remain on his current employment terms until new arrangements are finalized, the company said.
The medical device company's shares fell 6% in recent Monday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.